Global Metagenomics Market, By Product and Service (Reagents and Consumables, Instruments, Services, Analysis and Data Interpretation Solutions), Workflow (Sample Processing and Library Preparation, Sequencing, Data Processing and Analysis), Technology (Shotgun Metagenomic Sequencing, 16S rRNA Sequencing, Metatranscriptomics, Whole-genome Sequencing and De Novo Assembly), Application (Drug Discovery, Clinical Diagnostics, Soil Microbiome Applications, Industrial applications, Ecological and Environmental Applications, Veterinary Applications, Other Applications), Country (U.S., Canada, Mexico, Germany, Italy, U.K., France, Spain, Netherland, Belgium, Switzerland, Turkey, Russia, Rest of Europe, Japan, China, India, South Korea, Australia, Singapore, Malaysia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific, Brazil, Argentina, Rest of South America, South Africa, Saudi Arabia, UAE, Egypt, Israel, Rest of Middle East & Africa) Industry Trends and Forecast to 2028
Market Analysis and Insights : Global Metagenomics Market
The metagenomics market is expected to witness market growth at a rate of 7.3% in the forecast period of 2021 to 2028. Data Bridge Market Research report on metagenomics market provides analysis and insights regarding the various factors expected to be prevalent throughout the forecast period while providing their impacts on the market’s growth. The expansion of healthcare sector globally is escalating the growth of metagenomics market.
Metagenomics is referred as the study of genetic material recovered from the environmental samples. The study is defined as a tool for microbial community that aims to study genes and microbial pathways. It provides powerful lens possessing the potential to understand the whole entire living world. The technology enables improved understanding of the microbial ecology and allows researchers to tap into a vast microbial diversity.
The rise in prevalence of genetic disorders across the globe acts as one of the major factors driving the growth of metagenomics market. The surge in initiatives and funding from government and private bodies for large-scale sequencing projects, and investments in development of bioinformatics platforms to support metagenomics and microbiome profiling accelerate the market growth. The rise in interest of researchers in associated novel research areas such as metatranscriptomics, metaproteomics, and metabolomics, and significant applications of metagenomics in various fields further influence the market. Additionally, high demand for dental surgeries, rise in medical and dental tourism, increase in geriatric population and surge in disposable income in developing countries positively affect the metagenomics market. Furthermore, availability of cloud computing for data management extend profitable opportunity to the market players in the forecast period of 2021 to 2028.
On the other hand, end-user budget constraints in developing countries and high cost of the technolohy are expected to obstruct the market growth. Storage of sequencing data and dearth of skilled professionals are projected to challenge the metagenomics market in the forecast period of 2021-2028.
This metagenomics market report provides details of new recent developments, trade regulations, import export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on metagenomics market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.
Global Metagenomics Market Scope and Market Size
- The metagenomics market is segmented on the basis of product and service, workflow, technology and application. The growth amongst these segments will help you analyze meagre growth segments in the industries, and provide the users with valuable market overview and market insights to help them in making strategic decisions for identification of core market applications.
- On the basis of product and service, the metagenomics market is segmented into reagents and consumables, instruments, services, and analysis and data interpretation solutions.
- On the basis of workflow, the metagenomics market is segmented into sample processing and library preparation, sequencing, and data processing and analysis.
- On the basis of technology, the metagenomics market is segmented into shotgun metagenomic sequencing, 16S rRNA sequencing, metatranscriptomics, whole-genome sequencing and de novo assembly.
- On the basis of application, the metagenomics market is segmented into drug discovery, clinical diagnostics, soil microbiome applications, industrial applications, ecological and environmental applications, veterinary applications and other applications.
Metagenomics Market Country Level Analysis
The metagenomics market is analyzed and market size insights and trends are provided by country, product and service, workflow, technology and application as referenced above.
The countries covered in the metagenomics market report are the U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.
North America dominates the metagenomics market because of the presence of a substantial number of prominent biotechnology companies within the region. Asia-Pacific is expected to witness significant growth during the forecast period of 2021 to 2028 due to the developments undertaken to strengthen the bioinformatics infrastructure and genomic landscape in countries such as India and China.
The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points like down-stream and upstream value chain analysis, technical trends and porter's five forces analysis, case studies are some of the pointers used to forecast the market scenario for individual countries. Also, the presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.
Healthcare Infrastructure growth Installed base and New Technology Penetration
The metagenomics market also provides you with detailed market analysis for every country growth in healthcare expenditure for capital equipment, installed base of different kind of products for metagenomics market, impact of technology using life line curves and changes in healthcare regulatory scenarios and their impact on the metagenomics market. The data is available for historic period 2010-2019.
Competitive Landscape and Metagenomics Market Share Analysis
The metagenomics market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies’ focus related to metagenomics market.
The major players covered in the metagenomics market report are Agilent Technologies, Inc, ENTEROME, IntegraGen, Oxford Nanopore Technologies, QIAGEN, Illumina, Inc, Pacific Biosciences of California, Inc, Swift Biosciences Inc., Thermo Fisher Scientific Inc., BGI, Bio-Rad Laboratories, Inc., and Promega Corporation., among other domestic and global players. Market share data is available for global, North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South America separately. DBMR analysts understand competitive strengths and provide competitive analysis for each competitor separately.
SKU-
